Skip to content

Regulatory Press Releases

KALLELSE TILL ÅRSSTÄMMA I PILA PHARMA AB

Malmö i mars 2024 Download the press release as PDF here Aktieägarna i PILA PHARMA AB, org.nr 556966-4831 ("PILA PHARMA" eller "Bolaget"), kallas härmed till årsstämma tisdag den 18 april 2024 kl. 15.00 hos MAQS Advokatbyrå, Gibraltargatan 7 i Malmö. Registrering till stämman börjar kl. 14.30. Anmälan Aktieägare, som önskar delta vid årsstämman, ska (i) dels vara införd i den av Euroclear Sweden…

Read more

PILA PHARMA PUBLISHES THE ANNUAL REPORT 2023

Malmö, 20 March 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) announces that the annual report (in Swedish) is now available on the Company´s homepage, https://pilapharma.com/investors/finansiell-information/, and as an attachment to this press release. " The year 2023 was when the global interest in treatments of obesity became a megatrend! This is interesting for…

Read more

PILA PHARMA ADVANCES THE PUBLICATION OF THE ANNUAL REPORT 2023

Malmö, 20 March 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) has decided to advance the publication of its annual report for the financial year ended 31 December 2023 to the 20 March 2024. The previous date for the publication of the annual report for the financial year ended 31 December 2023 was…

Read more

PILA PHARMA PUBLISHES YEAR-END REPORT (1 January – 31 December 2023)

Malmö, 28 February, 2024 Download the press release as PDF here PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s year-end report for the period January - December 2023. The report can be found on the Company´s website: https://pilapharma.com/investors/finansiell-information/ SUMMARY OF YEAR-END REPORT  Fourth quarter (1 October - 31 December 2023) Revenue was 366 kSEK (413) Operating loss (EBIT)…

Read more

Pila Pharma AB announces outcome in the rights issue

Malmö, 5 December 2023 Download the press release as PDF here NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA, NEW ZEALAND, RUSSIA, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD…

Read more
Back To Top